Q2 2026 saw strong organic growth, margin expansion, and a 14% rise in Core EPS, prompting upgraded full-year guidance. Both Fresenius Kabi and Helios delivered robust performance, with improved profitability and returns on capital.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.